Conor Ramps Up Production Of CoStar Stent To Prep For U.S. Launch
This article was originally published in The Gray Sheet
Executive Summary
Conor Medsystems is already boosting manufacturing capacity in preparation for the U.S. launch of its CoStar drug-eluting stent, though the product is not slated to hit the market until late next year at the earliest